IRIS
ZENTILIN, PATRIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 21.561
AS - Asia 2.263
NA - Nord America 1.951
Continente sconosciuto - Info sul continente non disponibili 267
SA - Sud America 214
AF - Africa 25
OC - Oceania 8
Totale 26.289
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 21.192
US - Stati Uniti d'America 1.801
SG - Singapore 863
CN - Cina 595
VN - Vietnam 374
BD - Bangladesh 192
FR - Francia 186
BR - Brasile 122
HK - Hong Kong 81
CA - Canada 63
DE - Germania 37
AR - Argentina 36
GB - Regno Unito 36
MX - Messico 32
IN - India 31
FI - Finlandia 30
JP - Giappone 27
IQ - Iraq 21
EC - Ecuador 17
NL - Olanda 14
CO - Colombia 13
IE - Irlanda 13
PH - Filippine 12
ID - Indonesia 11
JM - Giamaica 11
ES - Italia 10
VE - Venezuela 10
NI - Nicaragua 9
TR - Turchia 9
CL - Cile 8
CR - Costa Rica 7
GT - Guatemala 7
HN - Honduras 6
JO - Giordania 6
AU - Australia 5
LT - Lituania 5
PE - Perù 5
RU - Federazione Russa 5
TH - Thailandia 5
CH - Svizzera 4
OM - Oman 4
SA - Arabia Saudita 4
SE - Svezia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
ZA - Sudafrica 4
DZ - Algeria 3
NP - Nepal 3
PL - Polonia 3
PY - Paraguay 3
SV - El Salvador 3
UA - Ucraina 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
FJ - Figi 2
KR - Corea 2
MA - Marocco 2
MY - Malesia 2
PA - Panama 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BY - Bielorussia 1
BZ - Belize 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GP - Guadalupe 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PR - Porto Rico 1
RO - Romania 1
Totale 26.018
Salva come PNG Salva come JPEG
Città #
Genova 12.851
Genoa 4.957
Rapallo 1.742
Vado Ligure 1.357
San Jose 435
Singapore 384
Lauterbourg 171
Ashburn 157
Ho Chi Minh City 134
Beijing 96
New York 96
Hong Kong 80
Hanoi 77
Council Bluffs 51
Santa Clara 49
Los Angeles 47
Orem 36
Bordighera 34
Milan 32
Frankfurt am Main 29
Buffalo 26
Helsinki 25
Tokyo 25
Chicago 21
Rome 21
Dallas 20
Mexico City 19
Da Nang 17
Philadelphia 17
Atlanta 15
Phoenix 15
Tianjin 15
Montreal 14
St Louis 14
Dublin 12
Haiphong 12
Poplar 11
Toronto 11
Boardman 10
Bologna 10
Brooklyn 10
Chennai 10
Amsterdam 9
Boston 9
Florence 9
Naples 9
Seattle 9
City of London 8
Columbus 8
Greensboro 8
Kingston 8
Las Vegas 8
São Paulo 8
Charlotte 7
Guangzhou 7
Hải Dương 7
Managua 7
Mumbai 7
Orlando 7
Quito 7
San Francisco 7
San José 7
Washington 7
Amman 6
Cagliari 6
Guatemala City 6
Hamilton 6
Houston 6
Medford 6
Memphis 6
Ocala 6
San Diego 6
Shanghai 6
Baghdad 5
Brescia 5
Can Tho 5
Guayaquil 5
Lappeenranta 5
London 5
Omaha 5
Padua 5
Rio de Janeiro 5
The Bronx 5
Thái Bình 5
Bari 4
Billings 4
Curitiba 4
Denver 4
Des Moines 4
Dhaka 4
Durham 4
Flint 4
Lima 4
Louisville 4
Madison 4
Mansfield 4
Mobile 4
Muscat 4
Palermo 4
Paris 4
Totale 23.507
Salva come PNG Salva come JPEG
Nome #
Proton pump inhibitors: use and misuse in the clinical setting 249
Hepatobiliary and Pancreatic: A rare cause of portal hypertension. 245
Characteristics of gastro-esophageal reflux episodes in Barrett's esophagus, erosive esophagitis and healthy volunteers 223
A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer. 223
Time pattern of gastric acidity in Barrett's esophagus 210
Advancements in the use of manometry and impedance testing for esophageal functional disorders 210
Reassessment of the diagnostic value of histology in patients with GERD, using multiple biopsy sites and an appropriate control group 209
Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease 206
Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease. 204
A safety review of proton pump inhibitors to treat acid-related digestive diseases 202
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD) 200
Alginate controls heartburn in patients with erosive and nonerosive reflux disease. 200
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD) 200
A comparison between sodium alginate and magaldrate anhydrous in the treatment of patients with gastroesophageal reflux symptoms. 197
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial 196
A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine. 194
Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al. 194
Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure. 191
Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn. 189
Drugs for improving esophageal mucosa defense: Where are we now and where are we going? 189
The relevance of symptom association analysis in GORD patients undergoing anti-reflux surgery 186
Cell proliferation of squamous epithelium in gastro-oesophageal reflux disease: correlations with clinical, endoscopic and morphological data 186
24-hour gastric pH and extent of duodenal gastric metaplasia in Helicobacter pylori-positive patients. 185
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. 185
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? 185
An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry. 180
Achalasia with Dense Eosinophilic Infiltrate Responding To Steroidal Treatment. 178
Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine. 176
Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity. 174
Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer. 174
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. 171
Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients. 170
Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients. 168
Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum. 168
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 168
New insight in the mechanism of omeprazole antimicrobial combinations to eradicate Helicobacter pylori. 167
Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations 166
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 163
Endotherapy for and tailored approaches to treating GERD, and refractory GERD 162
24-hour study of gastric acidity in normal subjects and in cholecystectomized patients using continuous pH monitoring. 161
The appropriate use of proton-pump inhibitors 161
Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients 160
Esophageal biopsies in the management of GERD: complementary tool for many but not for all. 160
Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring. 159
Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer. 159
Microscopic Esophagitis is More Frequent in Patients With pH-Positive Non-Erosive Reflux Disease and Hypersensitive Esophagus Than in Those With Functional Heartburn: A Study Using Impedance-pH and Optical Microscopy. 159
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole 159
24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes. 159
NERD: an umbrella term including heterogeneous subpopulations. 158
Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor. 157
Antisecretory effect of three premeal doses of cimetidine 400 mg versus a single morning dose of omeprazole 20 mg: pathophysiological implications for duodenal ulcer treatment. 156
Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity 155
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole. 153
Epidemiology and natural history of gastroesophageal reflux disease 153
Helicobacter pylori and tolerance to H2-blockers. 152
Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori 151
Esophageal acid exposure still plays a major role in patients with NERD. 151
Carditis in patients with gastro-oesophageal reflux disease: results of a controlled study based on both endoscopy and 24-h oesophageal pH monitoring. 149
Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non-erosive gastro-oesophageal reflux disease. 148
Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? 147
[Esophageal pH monitoring: factors influencing the definition of normality]. 146
Overweight is a risk factor for both erosive and non-erosive reflux disease. 146
MIB-1 Proliferation Index of squamous epithelium in gastroesophageal reflux disease. Correlations with clinical, Endoscopic and Morphological data. 145
Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. 145
Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis. 144
Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. 143
Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD) 141
Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study 141
Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease. 141
Basal cell hyperplasia and dilatation of intercellular spaces are the main histologic features associated to the endoscopic/impedance-pH diagnosis of GERD and its related mucosal integrity impairment 141
The role of Acid in functional dyspepsia. 140
Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation 140
The relevance of weakly acidic reflux in patients with Barrett's esophagus. 139
Relevance of measuring substances in bronchoalveolar lavage fluid for detecting aspiration-associated extraesophageal reflux disease 139
Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. 138
Limitations of continuous 24-h intragastric pH monitoring in the diagnosis of duodenogastric reflux 138
Studies on factors predicting GORD response to proton-pump inhibitors: NERD subpopulations need to be analysed separately. 138
Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD 138
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy. 137
Pathophysiological studies are mandatory to understand the benefit of proton pump inhibitors in patients with idiopathic pulmonary fibrosis 137
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. 137
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. 136
Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. 135
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. 135
Nonerosive reflux disease and functional heartburn are clearly separate entities. 135
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 135
Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease? 134
Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis. 134
Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage. 133
Comment to "current applications of evolving methodologies in gastroesophageal reflux disease testing". 133
Comparison of 24-h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer. 132
The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients. 132
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. 131
Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients. 131
Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study 130
Pathophysiological characteristics of long- and short-segment Barrett's oesophagus. 130
Intragastric acidity and serum gastrin after sufotidine. 128
Stool antigen assay (HpSA) is less reliable than urea breath test for post-treatment diagnosis of Helicobacter pylori infection. 128
Analysis of circadian fluctuations of bile salt concentration and pH in the stomach of normal subjects and patients suspected of having duodenogastric reflux. 128
Circadian acidity pattern in gastric ulcers at different sites. 127
Totale 16.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.166
article - articoli 74.278
book - libri 522
conference - conferenze 1.043
curatela - curatele 0
other - altro 7.174
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.149
Totale 168.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.102 107 156 179 282 75 144 163 405 82 210 65 234
2022/20232.094 223 130 21 190 442 312 1 167 367 13 203 25
2023/20241.019 49 123 24 115 94 157 64 49 59 21 83 181
2024/20253.309 160 253 152 206 440 331 284 494 133 133 360 363
2025/20266.199 728 157 447 576 652 595 935 263 491 601 313 441
2026/2027641 641 0 0 0 0 0 0 0 0 0 0 0
Totale 26.289